Additional file 4 of Targeting LINC02544/miR-497-5p/CAPRIN1 axis via exosome-based siRNA to overcome immunotherapy resistance in triple-negative breast cancer
Resistance to immunotherapy in TNBC is a major clinical challenge, necessitating an optimization in the therapeutic options for immunotherapy. The present study demonstrates the efficacy of targeting